2015
DOI: 10.2174/2213476x03666151105185505
|View full text |Cite
|
Sign up to set email alerts
|

A Rapid LC-ESI-MS/MS Method for the Quantitation of Salicylic Acid, an Active Metabolite of Acetylsalicylic Acid: Application to in vivo Pharmacokinetic and Bioequivalence Study in Indian Healthy Male Volunteers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…In this study, we have used hydrochlorothiazide as the IS, because it is a compound structurally similar to ASA; by using hydrochlorothiazide as the IS, a clean peak could be obtained without interference, with a fast detection time with proper retention time similar to those of ASA [ 26 ]. In addition, the analysis of ASA with hydrochlorothiazide as the IS showed that it was possible to detect low concentrations of ASA by optimizing the solvent buffer and column, and the fast detection time had the advantage of accelerating the time required for the analysis.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, we have used hydrochlorothiazide as the IS, because it is a compound structurally similar to ASA; by using hydrochlorothiazide as the IS, a clean peak could be obtained without interference, with a fast detection time with proper retention time similar to those of ASA [ 26 ]. In addition, the analysis of ASA with hydrochlorothiazide as the IS showed that it was possible to detect low concentrations of ASA by optimizing the solvent buffer and column, and the fast detection time had the advantage of accelerating the time required for the analysis.…”
Section: Discussionmentioning
confidence: 99%
“…The developed and validated LC−ESI−MS/MS assay method was applied to compare the bioavailability of two formulations of EPL by conducting the single oral dose, open label, randomized, two period, two sequence, crossover study [ 27 ] of 30 healthy Indian volunteers (male) with a mean age of 27.53 years (range 21–34 years), mean body weight of 60.23 kg (range 54–66 kg) and mean body height of 168.30 cm (range 162–174 cm) under fasting condition. After an overnight fasting period (10 h), each volunteer was administered either single dose of test preparation of EPL 20 mg Tablet (containing EPL maleate 20 mg, manufactured by JV LLC ‘Pharmland,’ The Republic of Belarus) or reference preparation Renitec 20 mg Tablet (containing EPL maleate 20 mg, manufactured by Merck Sharp & Dohme B.V., The Netherlands) with 240 ml of water, in the sequence determined by randomization.…”
Section: Methodsmentioning
confidence: 99%
“…For this open label, randomized, two period, two sequence, crossover study, [24][25][26][27] 24 healthy Indian volunteers (male) with a mean age of 25.23 AE 5.41 years and a mean body weight of 65.60 AE 3.64 kg have been selected. After an overnight fasting period (10 h), each volunteer was given either single dose of test preparation tablet (containing NSD 100 mg, manufactured by Pharmland JV Leninskaja STR, 124, 222603, Nesviz Belarus) or reference preparation tablet Nise (containing NSD 100 mg, manufactured by Dr. Reddy's Laboratories Ltd, Solan, India) with 240 mL of water, in the sequence determined by randomization.…”
Section: Bioequivalence Study and Pharmacokinetic Parametersmentioning
confidence: 99%